Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Culturally-focused Consultation for Asian Americans and Latino Americans [NA]
Clinical trial update from Massachusetts General Hospital reporting a completed study on culturally-focused consultation for Asian American …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Brief Culturally Adapted Cognitive Behaviour Therapy for Depression [NA]
A completed clinical trial evaluating Brief Culturally Adapted Cognitive Behaviour Therapy for Depression conducted by the Pakistan Associat…
-
FDA approval · 2014-10-28FDA Approved: QUETIAPINE FUMARATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original generic application for quetiapine fumarate, a second-generation antipsychotic used …
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Mindfulness Based Tinnitus Reduction (MBTR): A Symptom Perception Shift Program [Phase 2]
Phase 2 clinical trial evaluating the Mindfulness Based Tinnitus Reduction (MBTR) program as a symptom-perception shift intervention for tin…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Epidemiology and Prevention of Anxiety and Depression in Parents of Hospitalized Neonates [NA]
This completed clinical trial from Nanjing Medical University examined the epidemiology and prevention of anxiety and depression in parents …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-27FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic version of sertraline. This action …
-
CLINICAL_TRIALS withdrawal · 2014-10-27Clinical Trial Update: Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans [Phase 2]
Phase 2 trial evaluating adjunctive pregnenolone for PTSD and major depressive disorder in OEF/OIF veterans has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated memantine in combination with escitalopram in elderly patients with mild cognitive impairment and…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Cognitive Behavioral Therapy for Depression in Parkinson's Disease [NA]
A study evaluating cognitive behavioral therapy for depression in Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder [Phase 4]
This document provides an update on a Phase 4 randomized, controlled and open-label trial evaluating buspirone as add-on therapy for major d…
-
FDA approval · 2014-10-21FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine extended-release) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: This is a Study to Determine the Antidepressant Effects of AZD6765 [Phase 2]
A Phase 2 trial evaluated the antidepressant effects of AZD6765 in individuals with treatment-resistant major depressive disorder; results w…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Preventing Depression in the Children of Depressed African American Mothers [Phase 1]
Phase 1 clinical trial evaluating prevention of depression in children of depressed African American mothers. The study is completed with re…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy [Phase 4]
This Phase 4 clinical trial update investigates whether adding ketamine to sevoflurane anesthesia alters outcomes during electroconvulsive t…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. [NA]
A completed clinical trial evaluated FMPO for improving quality of care in people with severe mental illness; results were posted in 2014 fo…
-
FDA approval · 2014-10-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for fluoxetine.
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome [Phase 2]
A Phase 2 trial assessed pioglitazone for major depressive disorder in patients with metabolic syndrome; the study completed and results wer…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Phase I: At-Home Support for Rural Women Using Group Video Calling [Phase 1]
Phase I trial completion of an at-home group video calling support program for rural women, focusing on depression and post-traumatic stress…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating trazodone hydrochloride prolonged-release tablets for depression has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries [Phase 3]
A Phase 3 study of vortioxetine (Lu AA21004) for major depressive disorder in Asian countries has completed, with trial results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression [Phase 2]
Phase 2 trial update evaluating how to optimize the effectiveness of selective serotonin reuptake inhibitors in treatment-resistant depressi…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects [Phase 1]
This update reports the completion of a Phase 1 trial evaluating AZD6765 in depressed adults, comparing MRI effects of the drug to placebo.
-
CLINICAL_TRIALS research · 2014-10-13Clinical Trial Update: Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration [Phase 1]
Phase 1 pharmacokinetic study to assess the distribution, metabolism, and excretion of a single-dose intravenous [14C]AZD6765 in Major Depre…
-
FDA approval · 2014-10-10FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Efficacy Study of Korean Red Ginseng to Treat Depression [NA]
A clinical trial evaluating Korean Red Ginseng for the treatment of Major Depressive Disorder has completed. Results were posted in 2014.